News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
56,064 Results
Type
Article (3656)
Company Profile (33)
Press Release (52374)
Multimedia
Podcasts (21)
Webinars (6)
Section
Business (19998)
Career Advice (237)
Deals (2724)
Drug Delivery (21)
Drug Development (5518)
Employer Resources (24)
FDA (767)
Job Trends (1068)
News (26375)
Policy (1694)
Tag
2025 Best Places to Work (2)
2026 Best Places to Work (2)
2027 Biotech Bay Elite (1)
2027 Biotech Bay Standard (2)
2027 Biotech Beach Standard (1)
Academia (252)
Accelerated approval (1)
ADA (4)
Allergies (15)
Alliances (4619)
ALS (17)
Alzheimer's disease (120)
Antibody-drug conjugate (ADC) (74)
Approvals (782)
Artificial intelligence (100)
ASCO (25)
Autoimmune disease (50)
Automation (6)
Bankruptcy (22)
Belgium (2)
Best Places to Work (687)
BIO (14)
Biologics (12)
BIOSECURE Act (3)
Biosimilars (29)
BioSpace Insights (32)
Biotechnology (18)
Bispecific (6)
Bladder cancer (13)
Brain cancer (11)
Breast cancer (77)
Cancer (617)
Cardiovascular disease (24)
Career advice (197)
Career pathing (2)
CAR-T (68)
CDC (2)
CDMO (29)
Celiac Disease (1)
Cell therapy (157)
Cervical cancer (11)
Clinical research (4881)
Collaboration (331)
Commercialization (7)
Company closure (4)
Compensation (170)
Complete response letters (3)
COVID-19 (242)
CRISPR (19)
CRO (3)
C-suite (232)
Cystic fibrosis (9)
Data (945)
Decentralized trials (1)
Denatured (9)
Depression (19)
Dermatology (4)
Diabetes (33)
Diagnostics (653)
Digital health (4)
Diversity (3)
Diversity, equity & inclusion (6)
Drug discovery (79)
Drug pricing (14)
Drug shortages (1)
Duchenne muscular dystrophy (69)
Earnings (6363)
Editorial (7)
Employer branding (1)
Employer resources (20)
ESMO (31)
Events (8283)
Executive appointments (195)
Eye disease (2)
FDA (1166)
Fragile X (1)
Friedreich's ataxia (11)
Frontotemporal dementia (2)
Funding (296)
Gene editing (53)
Generative AI (8)
Gene therapy (123)
GLP-1 (99)
Government (298)
Guidances (44)
Healthcare (1166)
Hematology (18)
HIV (5)
Huntington's disease (17)
IgA nephropathy (19)
Immunology and inflammation (48)
Immuno-oncology (33)
Indications (17)
Infectious disease (271)
Inflammatory bowel disease (19)
Inflation Reduction Act (7)
Influenza (9)
Intellectual property (56)
Interviews (24)
IPO (1227)
IRA (9)
Job creations (357)
Job search strategy (166)
JPM (8)
Kidney cancer (15)
Kidney disease (11)
Labor market (18)
Layoffs (71)
Leadership (6)
Legal (307)
Licensing (16)
Liver cancer (11)
Longevity (7)
Lung cancer (57)
Lung diease (3)
Lymphoma (26)
Machine learning (7)
Management (8)
Manufacturing (158)
Marketing (2)
MASH (22)
Medical device (664)
Medtech (686)
Melanoma (20)
Mergers & acquisitions (1645)
Metabolic disorders (128)
Middle East (2)
mRNA (29)
Multiple sclerosis (31)
Multispecific (1)
Netherlands (3)
Neurodegenerative disease (63)
Neuropsychiatric disorders (17)
Neuroscience (333)
NextGen: Class of 2026 (527)
Non-profit (273)
Now hiring (19)
Obesity (59)
Opinion (37)
Ovarian cancer (37)
Pain (59)
Pancreatic cancer (37)
Parkinson's disease (19)
Partnered (11)
Patents (110)
Patient recruitment (81)
Patient selection (14)
Peanut (6)
People (6935)
Peptides (2)
Pharmaceutical (4)
Phase 1 (1892)
Phase 2 (2349)
Phase 3 (1457)
Pipeline (1383)
Policy (26)
Postmarket research (78)
Preclinical (850)
Press Release (5)
Prostate cancer (22)
Psychedelics (9)
Radioligand (1)
Radiopharmaceuticals (41)
Rare diseases (151)
Real estate (571)
Recruiting (11)
Regenerative medicine (3)
Regulatory (1653)
Reports (9)
Research institute (233)
Resumes & cover letters (49)
Rett syndrome (19)
RNA editing (8)
RSV (3)
Saudi Arabia (1)
Schizophrenia (24)
Series A (69)
Series B (34)
Sickle cell disease (8)
Special edition (3)
Spinal muscular atrophy (6)
Sponsored (3)
Startups (590)
Stomach cancer (4)
Supply chain (10)
Switzerland (2)
Tariffs (2)
The Weekly (12)
Vaccines (101)
Venture capital (29)
Weight loss (34)
Wet AMD (1)
Women's health (36)
Women in leadership (1)
Worklife (3)
Date
Last 7 days (69)
Last 30 days (327)
Last 365 days (2977)
2026 (2749)
2025 (2907)
2024 (3211)
2023 (3586)
2022 (4860)
2021 (5172)
2020 (4651)
2019 (3170)
2018 (2354)
2017 (2439)
2016 (2303)
2015 (2559)
2014 (1927)
2013 (1727)
2012 (1953)
2011 (1912)
2010 (1545)
Location
Africa (67)
Alabama (6)
Arizona (25)
Asia (2768)
Australia (555)
California (2553)
Canada (428)
China (170)
Colorado (97)
Connecticut (31)
Delaware (29)
Europe (6442)
Florida (140)
Georgia (29)
Hawaii (2)
Idaho (4)
Illinois (65)
India (12)
Indiana (88)
Japan (35)
Kansas (21)
Kentucky (2)
Louisiana (3)
Maine (2)
Maryland (113)
Massachusetts (1024)
Michigan (42)
Minnesota (44)
Mississippi (1)
Missouri (10)
Montana (1)
Nebraska (3)
Nevada (6)
New Hampshire (5)
New Jersey (300)
New York (220)
North Carolina (213)
North Dakota (1)
Northern California (1339)
Ohio (82)
Oklahoma (5)
Oregon (8)
Pennsylvania (212)
Puerto Rico (2)
Rhode Island (6)
South America (65)
South Carolina (6)
Southern California (1020)
Tennessee (9)
Texas (286)
United States (5690)
Utah (28)
Virginia (30)
Washington D.C. (4)
Washington State (155)
West Virginia (1)
Wisconsin (30)
56,064 Results for "element biosciences".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Element Biosciences Launches Cytos™, Scaling Multiomics to Labs of Every Size
October 19, 2026
·
4 min read
Press Releases
Element Biosciences Launches AVITI Dx™, Bringing CE-Marked IVD Sequencing to Ten EU Countries
October 29, 2026
·
2 min read
Press Releases
Element Biosciences Announces Upsized Series E to Accelerate Global Growth Across Ecosystem of Genomic, Multiomic, and Clinical Research Solutions
June 10, 2026
·
3 min read
Press Releases
Element Biosciences Introduces VITARI™, Redefining What High-Throughput Sequencing Makes Possible
February 19, 2026
·
2 min read
Press Releases
Battelle Researchers Demonstrate Biotech Breakthrough for Rare Earth Element Separation
September 1, 2026
·
3 min read
Job Trends
U.S. bioscience jobs up 7% from 2021 to 2025: Report
Bioscience employment rose in 41 states, though not in California, according to a new report from the Biotechnology Innovation Organization and the Council of State Bioscience Associations.
November 2, 2026
·
2 min read
·
Angela Gabriel
Press Releases
Myllia Biotechnology and Element Biosciences Demonstrate Successful Multimodal Optical Pooled Screening for Drug Discovery
Collaboration validates integrated RNA, protein, and morphology workflows and expands access to next generation optical pooled screening on the AVITI24™
March 16, 2026
·
1 min read
Press Releases
Laboratory Modernization Strengthens QPS Holdings, LLC’s Long-Term Commitment to Elemental Bioanalysis
August 31, 2026
·
3 min read
Press Releases
biomodal and Element Biosciences Combine Duet Multiomic and High-Throughput Sequencing Capabilities to Advance Clinical Research
February 23, 2026
·
3 min read
Press Releases
Finance & Accounting for Bioscience West debuts in San Diego this December
Discover innovative financial strategies and expert guidance from leading bioscience finance executives at this first-ever West Coast forum.
September 18, 2026
·
1 min read
1 of 5,607
Next